phosphorylethanolamine has been researched along with Disease Models, Animal in 11 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyridoxine-sensitive seizures characterize severe forms of infantile HPP." | 1.46 | Neuromuscular features of hypophosphatasia. ( Fonta, C; Salles, JP, 2017) |
| "Gonorrhea is one of the most common bacterial sexually transmitted infections, and increasing antibiotic resistance threatens the use of currently available antimicrobial therapies." | 1.39 | Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men. ( Anderson, JE; Balthazar, JT; Begum, AA; Carlson, RW; Duncan, JA; Ganguly, J; Hobbs, MM; Jerse, AE; Kandler, JL; Lin, JT; Shafer, WM; Sparling, PF, 2013) |
| "Novel and effective drugs against acute pancreatitis are required." | 1.38 | Metabolomic analysis to discover candidate therapeutic agents against acute pancreatitis. ( Azuma, T; Hayakumo, T; Izumi, Y; Kobayashi, T; Kutsumi, H; Nishiumi, S; Sakai, A; Shiomi, Y; Yoshida, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q | 1 |
| Yuan, M | 1 |
| Jiao, X | 1 |
| Ji, M | 1 |
| Huang, Y | 1 |
| Li, J | 1 |
| Li, D | 1 |
| Wang, G | 1 |
| Fonta, C | 1 |
| Salles, JP | 1 |
| Mambelli, LI | 1 |
| Teixeira, SF | 1 |
| Jorge, SD | 1 |
| Kawamura, B | 1 |
| Meneguelo, R | 1 |
| Barbuto, JAM | 1 |
| de Azevedo, RA | 1 |
| Ferreira, AK | 1 |
| Hobbs, MM | 1 |
| Anderson, JE | 1 |
| Balthazar, JT | 1 |
| Kandler, JL | 1 |
| Carlson, RW | 1 |
| Ganguly, J | 1 |
| Begum, AA | 1 |
| Duncan, JA | 1 |
| Lin, JT | 1 |
| Sparling, PF | 1 |
| Jerse, AE | 1 |
| Shafer, WM | 1 |
| Gupta, N | 1 |
| Ibrahim, HM | 1 |
| Ahsan, F | 1 |
| Jeon, MJ | 1 |
| Lee, Y | 1 |
| Ahn, S | 1 |
| Lee, C | 1 |
| Kim, OH | 1 |
| Oh, BC | 1 |
| Yu, U | 1 |
| Kim, H | 1 |
| Kishi, S | 1 |
| Campanholle, G | 1 |
| Gohil, VM | 1 |
| Perocchi, F | 1 |
| Brooks, CR | 1 |
| Morizane, R | 1 |
| Sabbisetti, V | 1 |
| Ichimura, T | 1 |
| Mootha, VK | 1 |
| Bonventre, JV | 1 |
| Li, C | 1 |
| Yan, Z | 1 |
| Yang, J | 1 |
| Chen, H | 1 |
| Li, H | 1 |
| Jiang, Y | 1 |
| Zhang, Z | 1 |
| Sakai, A | 1 |
| Nishiumi, S | 1 |
| Shiomi, Y | 1 |
| Kobayashi, T | 1 |
| Izumi, Y | 1 |
| Kutsumi, H | 1 |
| Hayakumo, T | 1 |
| Azuma, T | 1 |
| Yoshida, M | 1 |
| Pavlov, VA | 1 |
| Phillis, JW | 1 |
| Ren, J | 1 |
| O'Regan, MH | 1 |
11 other studies available for phosphorylethanolamine and Disease Models, Animal
| Article | Year |
|---|---|
Metabolite profiles in the peritoneal cavity of endometriosis patients and mouse models.
Topics: Adult; Animals; Ascitic Fluid; Disease Models, Animal; Endometriosis; Ethanolamines; Female; Humans; | 2021 |
Neuromuscular features of hypophosphatasia.
Topics: Adult; Alkaline Phosphatase; Animals; Biomarkers; Brain Diseases; Chronic Pain; Disease Models, Anim | 2017 |
Phosphoethanolamine induces caspase-independent cell death by reducing the expression of C-RAF and inhibits tumor growth in human melanoma model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Caspases; Cell Cycle Checkpoints; Cell Mov | 2018 |
Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men.
Topics: Animals; Disease Models, Animal; Ethanolaminephosphotransferase; Ethanolamines; Female; Gene Knockou | 2013 |
Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Inhalation; Animals; Antihypertensive | 2014 |
High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
Topics: Animals; Disease Models, Animal; Ethanolamines; Glycerylphosphorylcholine; Liver Cirrhosis; Magnetic | 2015 |
Meclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Cell Respiration; Cytochromes c; Deoxyglucose; | 2015 |
Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats.
Topics: Animals; Antioxidants; Brain; Brain Infarction; Disease Models, Animal; Ethanolamines; Excitatory Po | 2010 |
Metabolomic analysis to discover candidate therapeutic agents against acute pancreatitis.
Topics: Acute Disease; Amino Acids; Animals; Arginine; Ceruletide; Citric Acid Cycle; Disease Models, Animal | 2012 |
[Different sensitivity biochemical mechanisms to mycobacterium tuberculosis of guinea pigs and rats].
Topics: Amino Acids; Animals; Disease Models, Animal; Disease Susceptibility; Ethanolamine; Ethanolamines; G | 1998 |
Studies on the effects of lactate transport inhibition, pyruvate, glucose and glutamine on amino acid, lactate and glucose release from the ischemic rat cerebral cortex.
Topics: Amino Acids; Animals; Biological Transport; Brain Ischemia; Cerebral Cortex; Coumaric Acids; Disease | 2001 |